EE9900524A - N-triasolüül-2-indoolkarboksamiidid ja nende kasutamine CCK-A agonistidena - Google Patents
N-triasolüül-2-indoolkarboksamiidid ja nende kasutamine CCK-A agonistidenaInfo
- Publication number
- EE9900524A EE9900524A EEP199900524A EEP9900524A EE9900524A EE 9900524 A EE9900524 A EE 9900524A EE P199900524 A EEP199900524 A EE P199900524A EE P9900524 A EEP9900524 A EE P9900524A EE 9900524 A EE9900524 A EE 9900524A
- Authority
- EE
- Estonia
- Prior art keywords
- indolecarboxamides
- cck
- triazolyl
- agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9705850A FR2763337B1 (fr) | 1997-05-13 | 1997-05-13 | Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant |
PCT/FR1998/000905 WO1998051686A1 (fr) | 1997-05-13 | 1998-05-06 | N-triazolyl-2-indolecarboxamides et leur utilisation comme agonistes de cck-a |
Publications (1)
Publication Number | Publication Date |
---|---|
EE9900524A true EE9900524A (et) | 2000-06-15 |
Family
ID=9506830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP199900524A EE9900524A (et) | 1997-05-13 | 1998-05-06 | N-triasolüül-2-indoolkarboksamiidid ja nende kasutamine CCK-A agonistidena |
Country Status (35)
Country | Link |
---|---|
EP (1) | EP0984960B1 (et) |
JP (1) | JP2001524980A (et) |
KR (1) | KR20010012541A (et) |
CN (1) | CN1263528A (et) |
AR (1) | AR011729A1 (et) |
AT (1) | ATE232207T1 (et) |
AU (1) | AU725530B2 (et) |
BR (1) | BR9811465A (et) |
CA (1) | CA2289573A1 (et) |
CO (1) | CO4940485A1 (et) |
CZ (1) | CZ289484B6 (et) |
DE (1) | DE69811223T2 (et) |
DK (1) | DK0984960T3 (et) |
DZ (1) | DZ2486A1 (et) |
EE (1) | EE9900524A (et) |
ES (1) | ES2190081T3 (et) |
FR (1) | FR2763337B1 (et) |
GT (1) | GT199800068A (et) |
HR (1) | HRP980258B1 (et) |
HU (1) | HUP0002763A3 (et) |
ID (1) | ID22911A (et) |
IL (1) | IL132903A0 (et) |
IS (1) | IS5235A (et) |
NO (1) | NO995513L (et) |
NZ (1) | NZ500637A (et) |
PL (1) | PL336772A1 (et) |
RU (1) | RU2175323C2 (et) |
SI (1) | SI0984960T1 (et) |
SK (1) | SK154299A3 (et) |
TR (1) | TR199902795T2 (et) |
TW (1) | TW396155B (et) |
UY (1) | UY24997A1 (et) |
WO (1) | WO1998051686A1 (et) |
YU (1) | YU57999A (et) |
ZA (1) | ZA983997B (et) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2802530B1 (fr) * | 1999-12-17 | 2002-02-22 | Sanofi Synthelabo | Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant |
BR0114888A (pt) * | 2000-10-26 | 2003-12-09 | Sanofi Synthelabo | Derivados de triazol e composições farmacêuticas compreendendo os mesmos |
FR2815963B1 (fr) * | 2000-10-26 | 2003-02-28 | Sanofi Synthelabo | Nouveaux derives du triazole et les compositions pharmaceutiques les contenant |
HUP0004741A2 (hu) * | 2000-11-28 | 2002-12-28 | Sanofi-Synthelabo | Kémiai eljárás tiazolszármazékok előállítására és új intermedier |
WO2003037332A1 (en) * | 2001-10-12 | 2003-05-08 | Bayer Pharmaceuticals Corporation | Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity |
EP1314733A1 (en) * | 2001-11-22 | 2003-05-28 | Aventis Pharma Deutschland GmbH | Indole-2-carboxamides as factor Xa inhibitors |
EP1479677A1 (en) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | New indole derivatives as factor xa inhibitors |
EP1532980A1 (en) | 2003-11-24 | 2005-05-25 | Novo Nordisk A/S | N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
GB0403038D0 (en) * | 2004-02-11 | 2004-03-17 | Novartis Ag | Organic compounds |
JP2010516768A (ja) * | 2007-01-26 | 2010-05-20 | メルク・シャープ・エンド・ドーム・コーポレイション | コレシストキニン−1レセプターモジュレーターとしての置換アミノピリミジン |
MX2011000628A (es) * | 2008-07-15 | 2011-02-25 | Novartis Ag | Derivados de heteroarilo como inhibidores de dgat1. |
RU2544862C2 (ru) * | 2009-06-09 | 2015-03-20 | Актелион Фармасьютиклз Лтд | Фторированные аминотриазольные производные |
EP2490658A1 (de) * | 2009-10-22 | 2012-08-29 | Henkel AG & Co. KGaA | Zusammensetzung zur formgebung keratinischer fasern enthaltend mit propylenoxid modifizierte stärke |
CN106928147A (zh) * | 2017-03-14 | 2017-07-07 | 华东师范大学 | 三环二萜类似物及其制备方法、及其在制备抗前列腺癌药物中的应用 |
CN107271623A (zh) * | 2017-07-27 | 2017-10-20 | 青岛啤酒股份有限公司 | 基于人体饱腹感的啤酒可饮性评价方法 |
JP2022552655A (ja) | 2019-10-07 | 2022-12-19 | キャリーオペ,インク. | Gpr119アゴニスト |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2701708B1 (fr) * | 1993-02-19 | 1995-05-19 | Sanofi Elf | Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament. |
FR2703995B1 (fr) * | 1993-04-16 | 1995-07-21 | Sanofi Elf | 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant. |
-
1997
- 1997-05-13 FR FR9705850A patent/FR2763337B1/fr not_active Expired - Fee Related
-
1998
- 1998-05-06 NZ NZ500637A patent/NZ500637A/xx unknown
- 1998-05-06 IL IL13290398A patent/IL132903A0/xx unknown
- 1998-05-06 JP JP54885398A patent/JP2001524980A/ja not_active Ceased
- 1998-05-06 SK SK1542-99A patent/SK154299A3/sk unknown
- 1998-05-06 CN CN98807175A patent/CN1263528A/zh active Pending
- 1998-05-06 DZ DZ980096A patent/DZ2486A1/xx active
- 1998-05-06 YU YU57999A patent/YU57999A/sh unknown
- 1998-05-06 DE DE69811223T patent/DE69811223T2/de not_active Expired - Fee Related
- 1998-05-06 EE EEP199900524A patent/EE9900524A/et unknown
- 1998-05-06 DK DK98924383T patent/DK0984960T3/da active
- 1998-05-06 RU RU99125773/04A patent/RU2175323C2/ru not_active IP Right Cessation
- 1998-05-06 ES ES98924383T patent/ES2190081T3/es not_active Expired - Lifetime
- 1998-05-06 AU AU76599/98A patent/AU725530B2/en not_active Ceased
- 1998-05-06 AT AT98924383T patent/ATE232207T1/de not_active IP Right Cessation
- 1998-05-06 CZ CZ19994006A patent/CZ289484B6/cs not_active IP Right Cessation
- 1998-05-06 EP EP98924383A patent/EP0984960B1/fr not_active Expired - Lifetime
- 1998-05-06 SI SI9830372T patent/SI0984960T1/xx unknown
- 1998-05-06 WO PCT/FR1998/000905 patent/WO1998051686A1/fr not_active Application Discontinuation
- 1998-05-06 CO CO98024703A patent/CO4940485A1/es unknown
- 1998-05-06 BR BR9811465-4A patent/BR9811465A/pt not_active IP Right Cessation
- 1998-05-06 TR TR1999/02795T patent/TR199902795T2/xx unknown
- 1998-05-06 HU HU0002763A patent/HUP0002763A3/hu unknown
- 1998-05-06 PL PL98336772A patent/PL336772A1/xx unknown
- 1998-05-06 CA CA002289573A patent/CA2289573A1/fr not_active Abandoned
- 1998-05-06 KR KR1019997010496A patent/KR20010012541A/ko not_active Application Discontinuation
- 1998-05-06 ID IDW991374A patent/ID22911A/id unknown
- 1998-05-11 AR ARP980102152A patent/AR011729A1/es active IP Right Grant
- 1998-05-12 UY UY24997A patent/UY24997A1/es not_active IP Right Cessation
- 1998-05-12 TW TW087107326A patent/TW396155B/zh active
- 1998-05-12 ZA ZA9803997A patent/ZA983997B/xx unknown
- 1998-05-13 HR HR980258A patent/HRP980258B1/xx not_active IP Right Cessation
- 1998-05-20 GT GT199800068A patent/GT199800068A/es unknown
-
1999
- 1999-10-29 IS IS5235A patent/IS5235A/is unknown
- 1999-11-11 NO NO995513A patent/NO995513L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID22889A (id) | Komposisi kopolimer etilena dan penggunaannya | |
BR9702553A (pt) | Composição cosmética e utilização | |
EE04144B1 (et) | Farmatseutiline kompositsioon ja selle kasutamine | |
FI990466A0 (fi) | Aktivaattorit ja laite | |
EE9700209A (et) | Dihüdropürimidiinid ja nende kasutamine | |
EE05169B1 (et) | Asendatud oksasolidinoonid ja nende kasutamine | |
EE200200251A (et) | Uued N-asabitsükloamiidi derivaadid ja nende kasutamine | |
NO20000125D0 (no) | Tiadiazolyl- og oksadiazolylfenyloksazolidinon- antibakterielle midler | |
TR199501305A2 (tr) | Heterosiklik bilesikler ve bunlarin hazirlanmasi ve kullanimi | |
ID24196A (id) | Komposisi dan penggunaan | |
BR9502407A (pt) | Composição lubrificante e concetrado | |
EE9900524A (et) | N-triasolüül-2-indoolkarboksamiidid ja nende kasutamine CCK-A agonistidena | |
FI964031A (fi) | Bentsamidijohdannainen, mainittua johdannaista sisältävät koostumukset ja sen käyttö | |
BR9509688A (pt) | Composto e composição farmacêutica | |
DK1140952T3 (da) | Phosphororganiske forbindelser og anvendelse heraf | |
FI971317A (fi) | Uusia heterosyklisiä, substituoituja imidatsolokinoksalinoneja, niiden valmistus ja käyttö | |
FI982682A0 (fi) | Uusi komposiitti ja sen käyttö | |
FI19992526A (fi) | Sahakokoonpano | |
FI972010A0 (fi) | Arrangemang i en borrningsanordning | |
BR9505130A (pt) | Composto e composiçao farmacêutica | |
DE59812220D1 (de) | Halte- und trageband | |
SE9900878D0 (sv) | New composition and use thereof | |
SE9703737D0 (sv) | Pharmaceutical composition and use | |
SE9803771D0 (sv) | Pharmaceutical composition and use | |
BA98291A (bs) | Epoksi-azetidinoni priprava i upotreba |